fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search
Covid-19

Sheba Tests New Kit that Smells the COVID-19 Pathogen

New Kit that Smells the COVID-19
NanoScent’s new testing kit implements a sensor-based smelling system to detect the virus in its earliest stages. Results are available in 30 seconds, with a 90% success rate.

Israeli startup NanoScent has developed a new test that uses nanoscale sensors to “smell” the pathogen that identifies COVID-19 carriers. The Israeli Innovation Authority and the Health Ministry helped to fund the design and development of this innovative testing kit.

The kit is composed of a disposable piece that connects to the nose, which is manufactured by Netafim, an Israeli company, along with electronic components manufactured by DreamTech, a South Korean company. Together, these elements work to sniff out a coronavirus patient within 30 seconds, and the results show a success rate of 90%.

How does the NanoScent kit work? Vapors are emitted by the decomposition process that occurs when the COVID-19 contagion enters the host’s nose or pharynx, and the device absorbs these vapors. This means that the kit can also identify asymptomatic coronavirus carriers – as soon as four days after the initial infection.

To test the pilot product, Sheba Medical Center has used it among dozens of patients. It has also been tested at several Magen David Adom drive-in test stations, as well as at Ichilov Hospital in Tel Aviv, and at Poriya Hospital in Tiberias.

The NanoScent test is not intended to replace the current swab-based diagnosis of the virus, but rather to provide an initial indication of infection. It is designed to serve a function that’s similar – yet more accurate – to the current temperature checks performed before entry to crowded places. For example, the testing kit can be utilized at airports, offices, stadiums, schools and campuses, and cultural institutions.

Thus far, several major international companies have already expressed interest in purchasing the product from NanoScent.

Related
Isenia’s Battle
Isenia’s Battle with Alveolar Sarcoma
At 17, Isenia, a native of Semey, Kazakhstan, noticed a lump on her leg the size of a small apple. Initially, Isenia and her family…
Read More
Colon and Rectal Cancer
News Mar 14.
Sheba Study Indicates Readily-Available Drugs May Prevent Metastasis in Colon and Rectal Cancer Patients
Favorable responses to the treatment were noted by Prof. Shamgar Ben-Eliyahu, a neuroscientist specializing in psychoneuroimmunology (PNI) at TAU’s Sagol School of Neuroscience and School…
Read More
Colitis Treatment
News Mar 09.
A New Drug Discovery and Personalized Treatment Approach for Ulcerative Colitis
Ulcerative colitis is a chronic disease of the large intestine in which the colon's lining becomes inflamed and develops tiny open sores or ulcers that…
Read More